Patients with cancer are at increased risk of arterial thromboembolic disease due to the presence of risk factors common to both the development of cancer and arterial thrombosis, the cancer itself, and the treatments provided to treat cancer. We review here the epidemiology and pathophysiology of arterial thromboembolic disease in cancer, along with its prevention and treatment strategies. We also propose a generalized approach for the management of arterial thromboembolic disease in this patient population.
癌症患者由于存在癌症与动脉血栓形成共有的风险因素、癌症本身以及癌症治疗措施，其动脉血栓栓塞性疾病的风险显著增加。本文综述了癌症患者动脉血栓栓塞性疾病的流行病学与病理生理学机制，并探讨其预防与治疗策略。同时，我们针对该患者群体提出了一套动脉血栓栓塞性疾病的综合管理方案。
肿瘤(癌症)患者之家